Haft Lutschtablette mit Hohem Anteil an Spärlich Löslichem Wirkstoff
Anmelder: Quest Products, LLC 🇺🇸
Details
- Veröffentlichungs-Nr.
- EP4806429
- Anmeldetag
- 10. März 2026
- Veröffentlichung
- 16. September 2026
- Rechtsraum
- EP
- IPC
- A61K9/24, A61K33/10
Abstract
An oral adhering lozenge including a sparsely water-soluble active ingredient is provided. In one aspect, an oral adhering lozenge having at least 5 milliequivalents (mEq) of acid neutralizing capacity is provided. The acid neutralization capacity may be achieved with at least 200 milligrams of a sparsely water-soluble antacid, such as calcium carbonate. To achieve a fast enough speed of dissolution with such a large quantity of sparsely water-soluble active ingredient, one or more water-soluble ingredients acting as a compression binder and/or bulking agent that dissolves quickly in water is included in an amount equal to greater than the sparsely soluble active ingredient in the non-adhesive layer.
Anmelder
- Firma
- Quest Products, LLC
- Land
- 🇺🇸 USA